2312 NEW ZEALAND GAZETTE, No. 89 9 AUGUST 2007

Product: DP-Carvedilol
Active Ingredient: Carvedilol 6.25mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Douglas Pharmaceuticals Ltd
Manufacturer: Pharmascience Inc, Montreal, Quebec, Canada

Dated this 2nd day of August 2007.

ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go5477

Classification of Medicines

Pursuant to section 106(1) of the Medicines Act 1981, I, Anthony Hill, Deputy Director-General, Sector Accountability and Funding Directorate, acting under delegated authority, hereby declare the following:

1. The medicines listed in Schedule 1 to this notice are classified as prescription medicines.

2. The medicines listed in Schedule 2 to this notice are classified as restricted medicines.

3. The medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.

Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.

Unless specific reference is made otherwise, every reference applies also to medicines that are:

(a) preparations and admixtures containing any proportion of any substance listed in the notice.

(b) salts and esters of any substance listed in the notice.

(c) preparations or extracts of biological materials listed in the notice.

(d) salts or oxides of elements listed in the notice.

Unless specific reference is made otherwise, every reference to a medicine applies:

(i) if the medicine is in an injection or eye preparation, to any concentration of that medicine; and

(ii) if the medicine is not in an injection or eye preparation, only if the concentration of the medicine or the concentration of the total active principles of the medicine is greater than 10 milligrams per litre or per kilogram.

Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.

Schedule 1

Prescription Medicines

Abatacept
Aliskiren
Amphotericin
Amyl nitrite; except when sold from outlets licensed to sell cyanide paste for the purpose of vertebrate pest control
Anagrelide
Azatadine; except when specified elsewhere in the Schedule
Azelastine; except in medicines for ophthalmic use containing 0.05% or less
Brompheniramine; except when specified elsewhere in the Schedule
Brugmansia spp
Chlorpheniramine; except when specified elsewhere in the Schedule
Chlorquinaldol
Choline salicylate; except in medicines containing 10% or less and in pack sizes of 15 grams or less

Darunavir
Dasatinib
Deslorelin
Dexchlorpheniramine; except when specified elsewhere in the Schedule
Dimenhydrinate; except when specified elsewhere in the Schedule
Dimethoxinate
Diphenhydramine; except when specified elsewhere in the Schedule
Diphenylpyraline
Doxylamine; except when specified elsewhere in the Schedule
Etidronic acid; except in medicines for external use containing 1% or less
Exenatide
Fomivirsen
Fosaprepitant
Ipriflavone
Lanthanum
Lapatinib
Lefetamine
Levonorgestrel; except when specified elsewhere in the Schedule; except in medicines for use as emergency post-coital contraception when sold by nurses recognised by their professional body as having competency in the field of sexual and reproductive health
Lithium; except when specified elsewhere in the Schedule; except when present as an excipient in dermal medicines containing 0.25% or less
Lodoxamide; except in medicines for ophthalmic use
Mepyramine; except when specified elsewhere in the Schedule
Natalizumab
Nepafenac
Nilotinib
Olmesartan
Oseltamivir; except when sold by a registered pharmacist between the months of May to September inclusive for the treatment of seasonal influenza to a consumer 12 years of age or more presenting in a pharmacy with early symptoms of influenza
Oxiconazole; except when specified elsewhere in the Schedule
Palifermin
Paliperidone
Paracetamol; except when specified elsewhere in the Schedule
Pegvisomant
Phenyltoloxamine
Promethazine; except when specified elsewhere in the Schedule